Tempest Therapeutics Inc (TPST) Stock Price

2.21 ▼ -0.05 (-2.21%)
Open: 2.235 Vol: 22.49K Day's range: 2.17 - 2.27 Mar 16, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TPST Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.21▼ 2.25▼ 2.25▼ 2.31▼ 2.29▼
MA10 2.22▼ 2.29▼ 2.29▼ 2.32▼ 2.46▼
MA20 2.28▼ 2.35▼ 2.35▼ 2.34▼ 3.41▼
MA50 2.36▼ 2.35▼ 2.32▼ 2.53▼ 6.33▼
MA100 2.36▼ 2.34▼ 2.34▼ 4.27▼ 12.95▼
MA200 2.34▼ 2.51▼ 2.58▼ 6.46▼ 21.30▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.007▼ -0.020▼ -0.020▼ 0.015▲ 0.086▲
RSI 32.331▼ 29.715▼ 30.364▼ 37.304▼ 26.694▼
STOCH 20.926     13.686▼ 13.686▼ 55.641     16.631▼
WILL %R -78.571▼ -87.500▼ -87.500▼ -74.576     -91.667▼
CCI -78.052     -141.097▼ -141.097▼ -111.551▼ -91.673    
Latest Filters Detected On TPST
MA $TPST Price Crossed Below MA(26) Set Alert
MA $TPST Price Crossed Below MA(13) Set Alert
MA $TPST Price Crossed Below MA(7) Set Alert
CDL $TPST Marubozu Candlestick Pattern Detected Set Alert
Tempest Therapeutics Inc News
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
Thursday, March 12, 2026 04:04 AM
Cincinnati Children’s Applied Gene and Cell Therapy Center selected to conduct tech transfer, development and IND-enabling manufacturingAll activities other than long-term stability testing planned to ...
Tempest Therapeutics: Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
Wednesday, March 11, 2026 07:39 AM
Cincinnati Children's Applied Gene and Cell Therapy Center selected to conduct tech transfer, development and IND-enabling manufacturingAll activities other than long-term stability testing planned to ...
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for ...
Tuesday, February 24, 2026 04:01 PM
BRISBANE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company developing a pipeline of advanced cell therapy and ...
TPST historical stock data
date open high low close volume
16/03/26 2.235 2.27 2.17 2.21 22,492
13/03/26 2.287 2.35 2.21 2.26 46,832
12/03/26 2.38 2.3801 2.28 2.29 61,970
11/03/26 2.42 2.43 2.37 2.40 42,956
10/03/26 2.39 2.474 2.36 2.40 83,009
09/03/26 2.29 2.40 2.28 2.39 74,145
06/03/26 2.28 2.33 2.23 2.31 36,348
05/03/26 2.34 2.46 2.25 2.31 64,609
04/03/26 2.20 2.3799 2.17 2.34 134,207
03/03/26 2.18 2.30 2.13 2.25 144,920
Quote Details
52wk Low:2.12
52wk High:12.23
Vol:22.49K
Avg Vol(3m):1.8M
1Y Chng:-76.21%
1M Chng:-10.53%
Add to Watch List
More Information
Index US Composite
Market Cap. 30.47M